Shareholders' Equity - Options Granted (Details) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Mar. 31, 2015
|
||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Shares | 1,380,000 | |||||||
January 17, 2014 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Grant Date | Jan. 02, 2015 | [1] | ||||||
Expire Date | Jan. 02, 2025 | |||||||
Shares | 500,000 | |||||||
Exercise Price | 3.88 | |||||||
Fair Value | 1,163 | [2] | ||||||
January 17, 2014 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Grant Date | Jan. 20, 2015 | [1] | ||||||
Expire Date | Jan. 20, 2025 | |||||||
Shares | 850,000 | |||||||
Exercise Price | 4.25 | |||||||
Fair Value | 2,550 | [2] | ||||||
January 22, 2014 | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Grant Date | Jan. 20, 2015 | [1],[3] | ||||||
Expire Date | Jan. 20, 2025 | |||||||
Shares | 30,000 | |||||||
Exercise Price | 4.25 | |||||||
Fair Value | 90 | [2] | ||||||
|